Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case–control study

MAFLD and cardiovascular events: what does the evidence show?

(2021) Jacob George et al.   Clinical Gastroenterology and Hepatology

Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

(2021) Gabriel Tayguara Silveira Guerreiro et al.   Hepatology International

Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study

(2021) Madunil Anuk Niriella et al.   PLoS One

Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study

(2021) Shuhei Fukunaga et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease

(2021) Ho Soo Chun et al.   Journal of Cachexia Sarcopenia and Muscle

Association between metabolic associated fatty liver disease and osteoarthritis using data from the Korean national health and nutrition examination survey (KNHANES)

(2021) A Lum Han   INFLAMMOPHARMACOLOGY

NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?—Results From NHANES III

(2021) Qi Huang et al.   Frontiers in Medicine

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’

(2020) Yasser Fouad et al.   LIVER INTERNATIONAL

Redefining non-alcoholic fatty liver disease: what's in a name?

(2020) The Lancet Gastroenterology & Hepatology   Lancet Gastroenterology & Hepatology

From NAFLD to MAFLD: Implications of a premature change in terminology

(2020) Zobair M Younossi et al.   HEPATOLOGY

Comparison of MAFLD and NAFLD diagnostic criteria in real world

(2020) Su Lin et al.   LIVER INTERNATIONAL

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   Hepatology International

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

(2020) Sakura Yamamura et al.   LIVER INTERNATIONAL

Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study

(2020) Hokyou Lee et al.   Clinical Gastroenterology and Hepatology

The NAFLD‐MAFLD debate: Eminence vs evidence

(2020) Yasser Fouad et al.   LIVER INTERNATIONAL

MAFLD and risk of CKD

(2020) Dan-Qin Sun et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

NASH in Lean Individuals

(2019) Ramy Younes et al.   SEMINARS IN LIVER DISEASE

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

(2019) Juhani Knuuti et al.   EUROPEAN HEART JOURNAL

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Editorial: Noninvasive Prediction of Hepatic Steatosis

(2014) Jeremy Cumberledge et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Development, External Validation and Comparative Assessment of a New Diagnostic Score for Hepatic Steatosis

(2014) Peter J Meffert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE